Archives
Press Releases
advertisement
March 25, 2020
- Updates from Lilly about insulin supply and affordability
- Tandem: No COVID-19 Interruption to Supplies Access (Updated Mar 23)
March 4, 2020
- FDA Clears InPen Diabetes Management System for Fixed Dosing and Meal Estimation
- Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller | Tandem Diabetes Care
- FDA Informs Patients, Providers and Manufacturers About Potential Cybersecurity Vulnerabilities in Certain Medical Devices with Bluetooth Low Energy
February 26, 2020
- Data Presented at International Diabetes Conference Further Demonstrate Benefits of Tandem Diabetes Care Automated Insulin Delivery Technologies | Tandem Diabetes Care
- Senseonics Announces a Positive Coverage Decision for Eversense CGM from Cigna
- Dexcom and Insulet Announce Commercial Agreement to Integrate the Dexcom G6 and Future G7 CGM into Insulet’s Omnipod Horizon™ Automated Insulin Delivery System
- Beta Bionics Appoints Martha Aronson and Sean Carney to its Board of Independent Directors
- Companion Medical’s InPen Diabetes Management System Receives FDA Clearance for use with Fiasp® Insulin
- Advanced Hybrid Closed Loop System Early Feasibility Data on Patients Undergoing Unannounced Meal Challenges Shows Promising Results
- Dexcom and DreaMed Diabetes Announce Collaboration to Integrate Dexcom CGM Data into DreaMed Advisor
- Beyond Type 1 Announces Collaboration with National Association of School Nurses to Raise Awareness for Warning Signs of Type 1 Diabetes
advertisement
